Remed Co.,Ltd.
Research Remed Co.,Ltd. (302550.KQ) on Bullrun: market cap KRW 71.12B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker302550.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 71.12B
- Financial periodQ2 2026
- RevenueKRW 7.37B
- Net incomeKRW 700.92M
- Free cash flow-KRW 249.55M
- Gross margin56.3%
Valuation Snapshot
latest market cap is KRW 71.12B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 71.12B | n/a | n/a | n/a |
Dividend history
About Remed Co.,Ltd.
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Remed Co.,Ltd.'s market cap?
Remed Co.,Ltd.'s market capitalization is KRW 71.12B.
What does Remed Co.,Ltd. do?
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles.